The size of the Asia Pacific Molecular Cytogenetics Market size was worth USD 461.25 million in 2021. This figure is further estimated to develop at a CAGR of 12.5% and value USD 831.19 million by 2026.
Molecular biology and cytogenetics are the two major fields studies of which are undertaken in molecular cytogenetics. The branch of science which studies chromosomes is termed Cytogenetics. The analysis of genetic variations or alterations through in-situ hybridization techniques is another field into which Molecular cytogenetics further delves.
The CGH technology category commands the largest market share of approximately 53% and is estimated to retain its leading position over the aforementioned forecast period. Rising awareness levels regarding the CGH techniques in molecular biology are likely to raise patient acceptance and widen the application horizon in molecular diagnostics.
Also, effective cancer diagnosis because of novel diagnostic biomarkers' characterization coupled with the development of high-resolution, genetic testing platforms that diagnose constitutional and acquired diseases is vital to this market segment's growth. A rising number of applications regarding the detection of complex chromosomal arrangements using multicolor FISH techniques and SNP-array analysis is another contributing factor for this segment's growth.
This research report on the Asia Pacific Molecular Cytogenetics Market has been segmented and sub-segmented into the following categories:
By Product:
By Technique:
By Application:
By End User:
By Country:
The growing geriatric population base, the prevalence of chronic diseases are the primary causes attributed to the above-mentioned observable trend. The rising prevalence of dengue presents a lucrative growth opportunity to the FISH technology about identifying potential agents in these diseases through various probe assays. It is third in terms of market share, capturing 22% of the market worldwide. Asia Pacific is predicted to hit the highest CAGR during the forecast period.
Noteworthy companies dominating the Asia Pacific Molecular Cytogenetics Market profiled in the report are Affymetrix, Inc, Agilent Technologies, Inc, Illumina, Inc, Abbott Laboratories, Bio-Rad Laboratories, Inc, Applied Spectral Imaging, Inc, Thermo Fisher Scientific (Life Technologies), Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Kits & Reagents
5.1.1.1 Testing Kits
5.1.1.2 Probes
5.1.1.3 Fluorescent Affinity Reagents
5.1.1.4 Other Kits & Reagents
5.1.2 Instruments
5.1.3 Consumables
5.1.4 Software & Services
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Technique
5.2.1 Comparative Genomic Hybridization
5.2.1.1 Array-Based Comparative Genomic Hybridization
5.2.1.2 Standard Comparative Genomic Hybridization
5.2.2 Fluorescence in Situ Hybridization
5.2.3 In Situ Hybridization
5.2.4 Other Techniques
5.2.5 Y-o-Y Growth Analysis, By Technique
5.2.6 Market Attractiveness Analysis, By Technique
5.2.7 Market Share Analysis, By Technique
5.3 Application
5.3.1 Genetic Disorders
5.3.2 Cancer
5.3.3 Personalised Medicine
5.3.4 Other Applications
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
5.4 End User
5.4.1 Clinical & Research Laboratories
5.4.2 Academic Research Institutes
5.4.3 Pharmaceutical and Biotechnology Companies
5.4.4 Other End Users
5.4.5 Y-o-Y Growth Analysis, By End User
5.4.6 Market Attractiveness Analysis, By End User
5.4.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technique
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Technique
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technique
6.1.5.4 By Application
6.1.5.5 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 F. Hoffmann-La Roche Ltd. (Switzerland)
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Danaher Corporation (U.S.)
8.3 Thermo Fisher Scientific
8.4 Inc. (U.S.)
8.5 Abbott Laboratories (U.S.)
8.6 Agilent Technologies (U.S.)
8.7 PerkinElmer, Inc. (U.S.)
8.8 Illumina, Inc. (U.S.)
8.9 Bio-Rad Laboratories (U.S.)
8.10 Oxford Gene Technology (U.K.)
8.11 Applied Spectral Imaging (U.S.)
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
